BRAMITOB

This brand name is authorized in Austria, Brazil, Estonia, Spain, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, United Kingdom

Active ingredients

The drug BRAMITOB contains one active pharmaceutical ingredient (API):

1 Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN

Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. Read about Tobramycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01GB01	Tobramycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 508503903131313
Country: EE	Ravimiamet	Identifier(s): 1438499
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 68621
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147912
Country: IE	Health Products Regulatory Authority	Identifier(s): 88749
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6881
Country: IT	Agenzia del Farmaco	Identifier(s): 036646038
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037888, 1063116, 1063117, 1071192
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 830801
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100175593